These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

140 related items for PubMed ID: 28420919

  • 1. Association of arginine vasopressin receptor 1a gene polymorphisms with hepatorenal syndrome.
    Wang C, Yu Z, Luo X, Ye J, Liu S, Miu L, Bao J, Wang F.
    J Pak Med Assoc; 2017 Apr; 67(4):577-579. PubMed ID: 28420919
    [Abstract] [Full Text] [Related]

  • 2. Terlipressin, a vasoactive prodrug recommended in hepatorenal syndrome, is an agonist of human V1, V2 and V1B receptors: Implications for its safety profile.
    Colson PH, Virsolvy A, Gaudard P, Charrabi A, Corbani M, Manière MJ, Richard S, Guillon G.
    Pharmacol Res; 2016 Nov; 113(Pt A):257-264. PubMed ID: 27586252
    [Abstract] [Full Text] [Related]

  • 3. Are single nucleotide polymorphisms in the oxytocin and vasopressin 1A/1B receptor genes likely candidates for variation in ejaculatory function?
    Jern P, Westberg L, Johansson A, Jonsson L, Corander J, Sandnabba NK, Santtila P.
    BJU Int; 2012 Dec; 110(11 Pt C):E1173-80. PubMed ID: 22882465
    [Abstract] [Full Text] [Related]

  • 4. Correlation between miRNA target site polymorphisms in the 3' UTR of AVPR1A and the risk of hypertension in the Chinese Han population.
    Zhang L, Liu J, Cheng P, Lv F.
    Biosci Rep; 2019 May 31; 39(5):. PubMed ID: 31053625
    [Abstract] [Full Text] [Related]

  • 5. Short article: Impact of genetic variation in the vasopressin 1a receptor on the development of organ failure in patients admitted for acute decompensation of liver cirrhosis.
    Kerbert AJ, Schaapman JJ, van der Reijden JJ, Amorós Navarro À, McCormick A, van Hoek B, Arroyo V, Ginès P, Jalan R, Vargas V, Stauber R, Verspaget HW, Coenraad MJ, CANONIC Study Investigators of the EASL-CLIF Consortium.
    Eur J Gastroenterol Hepatol; 2017 May 31; 29(5):535-538. PubMed ID: 28350742
    [Abstract] [Full Text] [Related]

  • 6. Replicative genetic association study between functional polymorphisms in AVPR1A and social behavior scales of autism spectrum disorder in the Korean population.
    Yang SY, Kim SA, Hur GM, Park M, Park JE, Yoo HJ.
    Mol Autism; 2017 May 31; 8():44. PubMed ID: 28808521
    [Abstract] [Full Text] [Related]

  • 7. Renal failure in chronic liver disease and the hepatorenal syndrome.
    Srivastava B, Alexander GJ.
    Br J Hosp Med (Lond); 2011 Sep 31; 72(9):497-503. PubMed ID: 22041830
    [No Abstract] [Full Text] [Related]

  • 8. Terlipressin Plus Albumin Is More Effective Than Albumin Alone in Improving Renal Function in Patients With Cirrhosis and Hepatorenal Syndrome Type 1.
    Boyer TD, Sanyal AJ, Wong F, Frederick RT, Lake JR, O'Leary JG, Ganger D, Jamil K, Pappas SC, REVERSE Study Investigators.
    Gastroenterology; 2016 Jun 31; 150(7):1579-1589.e2. PubMed ID: 26896734
    [Abstract] [Full Text] [Related]

  • 9. Predictors of hepatorenal syndrome in alcoholic liver cirrhosis.
    Janicko M, Veseliny E, Senajova G, Jarcuska P.
    Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2015 Dec 31; 159(4):661-5. PubMed ID: 25820623
    [Abstract] [Full Text] [Related]

  • 10. Clinical utility of urinary neutrophil gelatinase-associated lipocalin and serum cystatin C in a cohort of liver cirrhosis patients with renal dysfunction: a challenge in the diagnosis of hepatorenal syndrome.
    Gomaa SH, Shamseya MM, Madkour MA.
    Eur J Gastroenterol Hepatol; 2019 Jun 31; 31(6):692-702. PubMed ID: 30601335
    [Abstract] [Full Text] [Related]

  • 11. Associations Between Vocal Symptoms and Genetic Variants in the Oxytocin Receptor and Arginine Vasopressin 1A Receptor Gene.
    Holmqvist Jämsen S, Johansson A, Westberg L, Santtila P, von der Pahlen B, Simberg S.
    J Speech Lang Hear Res; 2017 Jul 12; 60(7):1843-1854. PubMed ID: 28687839
    [Abstract] [Full Text] [Related]

  • 12. Terlipressin and albumin vs albumin in patients with cirrhosis and hepatorenal syndrome: a randomized study.
    Martín-Llahí M, Pépin MN, Guevara M, Díaz F, Torre A, Monescillo A, Soriano G, Terra C, Fábrega E, Arroyo V, Rodés J, Ginès P, TAHRS Investigators.
    Gastroenterology; 2008 May 12; 134(5):1352-9. PubMed ID: 18471512
    [Abstract] [Full Text] [Related]

  • 13. Terlipressin in hepatorenal syndrome.
    Mazur JE, Cooper TB, Dasta JF.
    Ann Pharmacother; 2011 Mar 12; 45(3):380-7. PubMed ID: 21386023
    [Abstract] [Full Text] [Related]

  • 14. Circadian rhythm of arginine vasopressin in hepatorenal syndrome.
    Pasqualetti P, Festuccia V, Collacciani A, Acitelli P, Casale R.
    Nephron; 1998 Mar 12; 78(1):33-7. PubMed ID: 9453401
    [Abstract] [Full Text] [Related]

  • 15. Oxidative stress, NOx/l-arginine ratio and glutathione/glutathione S-transferase ratio as predictors of 'sterile inflammation' in patients with alcoholic cirrhosis and hepatorenal syndrome type II.
    Nickovic VP, Miric D, Kisic B, Kocic H, Stojanovic M, Buttice S, Kocic G.
    Ren Fail; 2018 Nov 12; 40(1):340-349. PubMed ID: 29658815
    [Abstract] [Full Text] [Related]

  • 16. Terlipressin and albumin in patients with cirrhosis and type I hepatorenal syndrome.
    Neri S, Pulvirenti D, Malaguarnera M, Cosimo BM, Bertino G, Ignaccolo L, Siringo S, Castellino P.
    Dig Dis Sci; 2008 Mar 12; 53(3):830-5. PubMed ID: 17939047
    [Abstract] [Full Text] [Related]

  • 17. Diagnostic significance of nitrates and nitrites and L-arginine, in development of hepatorenal syndrome in patients with end stage alcoholic liver cirrhosis.
    Nickovic V, Kocic G, Bjelakovic G, Pavlovic R, Stojanovic I, Katanic R, Stojanovic S, Djindjic B.
    Ren Fail; 2013 Mar 12; 35(5):633-9. PubMed ID: 23651488
    [Abstract] [Full Text] [Related]

  • 18. Hepatorenal syndrome in patients with cirrhosis.
    Moreau R.
    J Gastroenterol Hepatol; 2002 Jul 12; 17(7):739-47. PubMed ID: 12121502
    [Abstract] [Full Text] [Related]

  • 19. Association between arginine vasopressin 1a receptor (AVPR1a) promoter region polymorphisms and prepulse inhibition.
    Levin R, Heresco-Levy U, Bachner-Melman R, Israel S, Shalev I, Ebstein RP.
    Psychoneuroendocrinology; 2009 Jul 12; 34(6):901-8. PubMed ID: 19195791
    [Abstract] [Full Text] [Related]

  • 20. A study on clinical outcomes of combination of terlipressin and albumin in Hepatorenal Syndrome.
    Krishna R, Raj J, Dev D, Prasad SC, Reghu R, V SO.
    Scand J Gastroenterol; 2020 Jul 12; 55(7):860-864. PubMed ID: 32634332
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.